Ubs Asset Management Americas Inc Athenex, Inc. Transaction History

Ubs Asset Management Americas Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$3.71 - $5.13 $8,885 - $12,286	2,395 Added 5.83%	43,453 $200,000
Q1 2021 May 14, 2021	SELL	$4.08 - $14.75 $28,523 - $103,117	-6,991 Reduced 14.55%	41,058 $176,000
Q4 2020 Mar 01, 2021	SELL	$11.06 - $14.01 $8,306 - $10,521	-751 Reduced 1.54%	48,049 $531,000
Q3 2020 Nov 13, 2020	BUY	$10.26 - $14.55 $11,368 - $16,121	1,108 Added 2.32%	48,800 $590,000
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $5,943 - $11,503	-836 Reduced 1.72%	47,692 $656,000
Q1 2020 May 15, 2020	BUY	$5.71 - $15.85 $37,040 - $102,818	6,487 Added 15.43%	48,528 $375,000
Q4 2019 Feb 14, 2020	SELL	$9.6 - $17.75 $21,331 - $39,440	-2,222 Reduced 5.02%	42,041 $641,000
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $111,750 - $192,990	9,190 Added 26.2%	44,263 $538,000
Q2 2019 Aug 15, 2019	BUY	$9.44 - $19.8 $331,089 - $694,445	35,073 New	35,073 $0

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.